Literature DB >> 25374489

Could early anti-tumor necrosis factor therapy change the prognosis of Crohn's disease?

Byong Duk Ye1.   

Abstract

Entities:  

Year:  2014        PMID： 25374489      PMCID： PMC4214950          DOI： 10.5217/ir.2014.12.4.263

Source DB:  PubMed          Journal:  Intest Res        ISSN： 1598-9100


× No keyword cloud information.
  10 in total

1.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

Review 2.  Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.

Authors:  William J Sandborn; Stephen Hanauer; Gert Van Assche; Julián Panés; Stephanie Wilson; Joel Petersson; Remo Panaccione
Journal:  J Crohns Colitis       Date:  2014-04-06       Impact factor: 9.071

3.  Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.

Authors:  A V Ramadas; S Gunesh; G A O Thomas; G T Williams; A B Hawthorne
Journal:  Gut       Date:  2010-07-21       Impact factor: 23.059

4.  Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.

Authors:  Peter Laszlo Lakatos; Petra Anna Golovics; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Agnes Horvath; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Gabor Veres; Barbara Dorottya Lovasz; Miklos Szathmari; Lajos S Kiss; Laszlo Lakatos
Journal:  Am J Gastroenterol       Date:  2012-01-10       Impact factor: 10.864

5.  Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.

Authors:  E Domènech; Y Zabana; E Garcia-Planella; A López San Román; P Nos; D Ginard; J Gordillo; F Martínez-Silva; B Beltrán; M Mañosa; E Cabré; M A Gassull
Journal:  Aliment Pharmacol Ther       Date:  2009-10-13       Impact factor: 8.171

6.  Step up versus early biologic therapy for Crohn's disease in clinical practice.

Authors:  Leyla J Ghazi; Seema A Patil; Ankur Rustgi; Mark H Flasar; Sanam Razeghi; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

7.  Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.

Authors:  Julián Panés; Antonio López-Sanromán; Fernando Bermejo; Valle García-Sánchez; Maria Esteve; Yolanda Torres; Eugeni Domènech; Marta Piqueras; María Gomez-García; Ana Gutiérrez; Carlos Taxonera; Miquel Sans
Journal:  Gastroenterology       Date:  2013-06-13       Impact factor: 22.682

8.  Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.

Authors:  Jacques Cosnes; Anne Bourrier; David Laharie; Stéphane Nahon; Yoram Bouhnik; Franck Carbonnel; Matthieu Allez; Jean-Louis Dupas; Jean-Marie Reimund; Guillaume Savoye; Pauline Jouet; Jacques Moreau; Jean-Yves Mary; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2013-04-30       Impact factor: 22.682

9.  Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004).

Authors:  Laurent Peyrin-Biroulet; W Scott Harmsen; William J Tremaine; Alan R Zinsmeister; William J Sandborn; Edward V Loftus
Journal:  Am J Gastroenterol       Date:  2012-09-04       Impact factor: 10.864

10.  Long-term clinical outcomes of korean patient with Crohn's disease following early use of infliximab.

Authors:  Nam Hee Kim; Yoon Suk Jung; Chang Mo Moon; Shin Yeong Lee; Eun Ran Kim; Young Ho Kim; Chang Kyun Lee; Suck Ho Lee; Jae Hak Kim; Kyu Chan Huh; Soon Man Yoon; Hyun Joo Song; Sun-Jin Boo; Hyun Joo Jang; You Sun Kim; Kang-Moon Lee; Jeong Eun Shin; Dong Il Park
Journal:  Intest Res       Date:  2014-10-27
  10 in total
  4 in total

Review 1.  Therapeutic strategies in Crohn's disease in an emergency surgical setting.

Authors:  Maria Michela Chiarello; Gilda Pepe; Valeria Fico; Valentina Bianchi; Giuseppe Tropeano; Gaia Altieri; Giuseppe Brisinda
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

2.  The clinical characteristics of patients with free perforation in Korean Crohn's disease: results from the CONNECT study.

Authors:  Young Seok Doh; You Sun Kim; Song I Bae; Jong Pil Im; Jae Hee Cheon; Byong Duk Ye; Ji Won Kim; Young Sook Park; Ji Hyun Lee; Young-Ho Kim; Joo Sung Kim; Dong Soo Han; Won Ho Kim
Journal:  BMC Gastroenterol       Date:  2015-03-18       Impact factor: 3.067

3.  Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study.

Authors:  Chang Mo Moon; Sung-Ae Jung; Seong-Eun Kim; Hyun Joo Song; Yunho Jung; Byong Duk Ye; Jae Hee Cheon; You Sun Kim; Young-Ho Kim; Joo Sung Kim; Dong Soo Han
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

4.  Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study.

Authors:  Jooyoung Lee; Jong Pil Im; Kyungdo Han; Seona Park; Hosim Soh; Kukhwan Choi; Jihye Kim; Jaeyoung Chun; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2019-11-14       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.